Lanthanide labeling of a potent protease activated receptor-2 agonist for time-resolved fluorescence analysis

Bioconjugate Chemistry

Volumn 23, Issue 10, 2012, Pages 2098-2104

  Hoffman, Justin ^a   Flynn, Andrea N ^a   Tillu, Dipti V ^a   Zhang, Zhenyu ^a   Patek, Renata ^a   Price, Theodore J ^a   Vagner, Josef ^a   Boitano, Scott ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASSAYS; ENZYME ACTIVITY; FLUORESCENCE; PEPTIDES; RARE EARTH ELEMENTS; THROUGHPUT;

AFFINITY-BINDING ASSAYS; AMINO TERMINUS; EXTRACELLULAR; G PROTEIN COUPLED RECEPTORS; HIGH-THROUGHPUT; LABELINGS; PEPTIDOMIMETICS; PROTEASE-ACTIVATED RECEPTOR 2; TETHERED LIGAND; TIME-RESOLVED FLUORESCENCE ANALYSIS;

LIGANDS;

2 FUROYL LIGRLO (DIETHYLENETRIAMINEPENTAACETIC ACID) NH2 (2 F LIGRLO DIETHYLENETRIAMINEPENTAACETIC ACID); EUROPIUM; LANTHANIDE; PENTETIC ACID; PROTEINASE ACTIVATED RECEPTOR 2; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BINDING ASSAY; CLINICAL EVALUATION; CONTROLLED STUDY; DRUG POTENCY; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; RAT;

EID: 84867519725     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc300300q     Document Type: Article

References (27)

1. Adams, M. N., Ramachandran, R., Yau, M. K., Suen, J. Y., Fairlie, D. P., Hollenberg, M. D., and Hooper, J. D. (2011) Structure, function and pathophysiology of protease activated receptors Pharmacol. Ther. 130, 248-282
2. Kanke, T., Takizawa, T., Kabeya, M., and Kawabata, A. (2005) Physiology and pathophysiology of proteinase-activated receptors (PARs): PAR-2 as a potential therapeutic target J. Pharmacol. Sci. 97, 38-42 (Pubitemid 40313097)
3. Ramachandran, R. and Hollenberg, M. D. (2008) Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more Br. J. Pharmacol. 153 (Suppl 1) S263-S282
4. Russo, A., Soh, U. J., and Trejo, J. (2009) Proteases display biased agonism at protease-activated receptors: location matters! Mol. Interventions 9, 87-96
5. Ramachandran, R., Noorbakhsh, F., Defea, K., and Hollenberg, M. D. (2012) Targeting proteinase-activated receptors: therapeutic potential and challenges Nature Rev. Drug Discovery 11, 69-86
6. 2) J. Biol. Chem. 286, 24638-24648
7. Stalheim, L., Ding, Y., Gullapalli, A., Paing, M. M., Wolfe, B. L., Morris, D. R., and Trejo, J. (2005) Multiple independent functions of arrestins in the regulation of protease-activated receptor-2 signaling and trafficking Mol. Pharmacol. 67, 78-87 (Pubitemid 40069968)
8. Ramachandran, R., Mihara, K., Mathur, M., Rochdi, M. D., Bouvier, M., Defea, K., and Hollenberg, M. D. (2009) Agonist-biased signaling via proteinase activated receptor-2: differential activation of calcium and mitogen-activated protein kinase pathways Mol. Pharmacol. 76, 791-801
9. 2 stimulate multiple signaling pathways to induce physiological responses in vitro and in vivo J. Biol. Chem. 286, 19076-19088
10. Hollenberg, M. D., Renaux, B., Hyun, E., Houle, S., Vergnolle, N., Saifeddine, M., and Ramachandran, R. (2008) Derivatized 2-furoyl-LIGRLO-amide, a versatile and selective probe for proteinase-activated receptor 2: binding and visualization J. Pharmacol. Exp. Ther. 326, 453-462
11. Al-Ani, B., Saifeddine, M., Kawabata, A., Renaux, B., Mokashi, S., and Hollenberg, M. D. (1999) Proteinase-activated receptor 2 (PAR(2)): development of a ligand-binding assay correlating with activation of PAR(2) by PAR(1)- and PAR(2)-derived peptide ligands J. Pharmacol. Exp. Ther. 290, 753-760 (Pubitemid 29344572)
12. Kanke, T., Ishiwata, H., Kabeya, M., Saka, M., Doi, T., Hattori, Y., Kawabata, A., and Plevin, R. (2005) Binding of a highly potent protease-activated receptor-2 (PAR2) activating peptide, [3H]2-furoyl-LIGRL-NH2, to human PAR2 Br. J. Pharmacol. 145, 255-263 (Pubitemid 40756530)
13. Kanke, T., Kabeya, M., Kubo, S., Kondo, S., Yasuoka, K., Tagashira, J., Ishiwata, H., Saka, M., Furuyama, T., Nishiyama, T., Doi, T., Hattori, Y., Kawabata, A., Cunningham, M. R., and Plevin, R. (2009) Novel antagonists for proteinase-activated receptor 2: inhibition of cellular and vascular responses in vitro and in vivo Br. J. Pharmacol. 158, 361-371
14. Hagan, A. K. and Zuchner, T. (2011) Lanthanide-based time-resolved luminescence immunoassays Anal. Bioanal. Chem. 400, 2847-2864
15. Josan, J. S., Vagner, J., Handl, H. L., Sankaranarayanan, R., Gillies, R. J., and Hruby, V. J. (2008) Solid-Phase Synthesis of Heterobivalent Ligands Targeted to Melanocortin and Cholecystokinin Receptors Int. J. Pept. Res. Ther. 14, 293-300
16. Parker, D. (2004) Excitement in f block: structure, dynamics and function of nine-coordinate chiral lanthanide complexes in aqueous media Chem. Soc. Rev. 33, 156-165 (Pubitemid 38586664)
17. Handl, H. L., Vagner, J., Yamamura, H. I., Hruby, V. J., and Gillies, R. J. (2004) Lanthanide-based time-resolved fluorescence of in cyto ligand-receptor interactions Anal. Biochem. 330, 242-50 (Pubitemid 38760098)
18. Josan, J. S., De Silva, C. R., Yoo, B., Lynch, R. M., Pagel, M. D., Vagner, J., and Hruby, V. J. (2011) Fluorescent and lanthanide labeling for ligand screens, assays, and imaging. In Drug Design and Discovery: Methods and Protocols (Satyanarayanajois, S. D., Ed.) pp 89-126, Springer Science+Business Media, Secaucus, N.J.
19. Bunzli, J. C. and Piguet, C. (2005) Taking advantage of luminescent lanthanide ions Chem. Soc. Rev. 34, 1048-1077 (Pubitemid 41805039)
20. Handl, H. L. and Gillies, R. J. (2005) Lanthanide-based luminescent assays for ligand-receptor interactions Life Sci. 77, 361-371 (Pubitemid 40719218)
21. 2) J. Med. Chem. 54, 1308-1313
22. Boitano, S., Flynn, A. N., Sherwood, C. L., Schulz, S. M., Hoffman, J., Gruzinova, I., and Daines, M. O. (2011) Alternaria alternata serine proteases induce lung inflammation and airway epithelial cell activation via PAR2 Am. J. Physiol.: Lung Cell. Mol. Physiol. 300, L605-L614
23. Lau, C., Lytle, C., Straus, D. S., and DeFea, K. A. (2011) Apical and basolateral pools of proteinase-activated receptor-2 direct distinct signaling events in the intestinal epithelium American J. Physiol.: Cell Physiol. 300, C113-C123
24. Handl, H. L., Vagner, J., Yamamura, H. I., Hruby, V. J., and Gillies, R. J. (2005) Development of a lanthanide-based assay for detection of receptor-ligand interactions at the delta-opioid receptor Anal. Biochem. 343, 299-307 (Pubitemid 41074044)
25. Millar, R. P. and Newton, C. L. (2010) The year in G protein-coupled receptor research Mol. Endocrinol. 24, 261-274
26. Zheng, H., Loh, H. H., and Law, P. Y. (2010) Agonist-selective signaling of G protein-coupled receptor: mechanisms and implications IUBMB Life 62, 112-119
27. Soh, U. J., Dores, M. R., Chen, B., and Trejo, J. (2010) Signal transduction by protease-activated receptors Br. J. Pharmacol. 160, 191-203